<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(9)</volume><submitter>Wolfe AR</submitter><pubmed_abstract>Pancreatic ductal adenocarcinoma (PDAC) is characterized by its nutrient-scavenging ability, crucial for tumor progression. Here, we investigated the roles of caveolae-mediated endocytosis (CME) in PDAC progression. Analysis of patient data across diverse datasets revealed a strong association of high caveolin-1 (Cav-1) expression with higher histologic grade, the most aggressive PDAC molecular subtypes, and worse clinical outcomes. Cav-1 loss markedly promoted longer overall and tumor-free survival in a genetically engineered mouse model. Cav-1-deficient tumor cell lines exhibited significantly reduced proliferation, particularly under low nutrient conditions. Supplementing cells with albumin rescued the growth of Cav-1-proficient PDAC cells, but not in Cav-1-deficient PDAC cells under low glutamine conditions. In addition, Cav-1 depletion led to significant metabolic defects, including decreased glycolytic and mitochondrial metabolism, and downstream protein translation signaling pathways. These findings highlight the crucial role of Cav-1 and CME in fueling pancreatic tumorigenesis, sustaining tumor growth, and promoting survival through nutrient scavenging.</pubmed_abstract><journal>Science advances</journal><pagination>eadj3551</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10906919</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditions.</pubmed_title><pmcid>PMC10906919</pmcid><pubmed_authors>Halloran M</pubmed_authors><pubmed_authors>Frank P</pubmed_authors><pubmed_authors>Lisanti M</pubmed_authors><pubmed_authors>Schaeffer DF</pubmed_authors><pubmed_authors>Baie S</pubmed_authors><pubmed_authors>Thompson TC</pubmed_authors><pubmed_authors>Shyu DL</pubmed_authors><pubmed_authors>Packard R</pubmed_authors><pubmed_authors>Cui T</pubmed_authors><pubmed_authors>Corrales-Guerrero S</pubmed_authors><pubmed_authors>Wolfe AR</pubmed_authors><pubmed_authors>Williams TM</pubmed_authors><pubmed_authors>Renouf DJ</pubmed_authors><pubmed_authors>Robb R</pubmed_authors><pubmed_authors>Chen W</pubmed_authors><pubmed_authors>Castro-Aceituno V</pubmed_authors><pubmed_authors>Topham JT</pubmed_authors><pubmed_authors>Webb A</pubmed_authors><pubmed_authors>Denko N</pubmed_authors><pubmed_authors>Karasinska JM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditions.</name><description>Pancreatic ductal adenocarcinoma (PDAC) is characterized by its nutrient-scavenging ability, crucial for tumor progression. Here, we investigated the roles of caveolae-mediated endocytosis (CME) in PDAC progression. Analysis of patient data across diverse datasets revealed a strong association of high caveolin-1 (Cav-1) expression with higher histologic grade, the most aggressive PDAC molecular subtypes, and worse clinical outcomes. Cav-1 loss markedly promoted longer overall and tumor-free survival in a genetically engineered mouse model. Cav-1-deficient tumor cell lines exhibited significantly reduced proliferation, particularly under low nutrient conditions. Supplementing cells with albumin rescued the growth of Cav-1-proficient PDAC cells, but not in Cav-1-deficient PDAC cells under low glutamine conditions. In addition, Cav-1 depletion led to significant metabolic defects, including decreased glycolytic and mitochondrial metabolism, and downstream protein translation signaling pathways. These findings highlight the crucial role of Cav-1 and CME in fueling pancreatic tumorigenesis, sustaining tumor growth, and promoting survival through nutrient scavenging.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-04T20:40:41.497Z</modification><creation>2025-04-04T20:40:41.497Z</creation></dates><accession>S-EPMC10906919</accession><cross_references><pubmed>38427741</pubmed><doi>10.1126/sciadv.adj3551</doi></cross_references></HashMap>